Disease, Disability, and Injury Prevention and Control Special Interest Projects (SIPs): Initial Review, 31358-31359 [2012-12730]
Download as PDF
<![CDATA[
31358
Federal Register / Vol. 77, No. 102 / Friday, May 25, 2012 / Notices
appointed the sole receiver for the
following financial institutions effective
as of the Date Closed as indicated in the
listing. This list (as updated from time
to time in the Federal Register) may be
relied upon as ‘‘of record’’ notice that
the Corporation has been appointed
receiver for purposes of the statement of
policy published in the July 2, 1992
issue of the Federal Register (57 FR
29491). For further information
concerning the identification of any
institutions which have been placed in
liquidation, please visit the Corporation
Web site at www.fdic.gov/bank/
individual/failed/banklist.html or
contact the Manager of Receivership
Oversight in the appropriate service
center.
Dated: May 21, 2012.
Federal Deposit Insurance Corporation.
Pamela Johnson,
Regulatory Editing Specialist.
INSTITUTIONS IN LIQUIDATION
[In alphabetical order]
FDIC Ref. No.
Bank name
City
10440 .................
Alabama Trust Bank, National Association ............................................
Sylacauga ..........
BILLING CODE 6714–01–P
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–12760 Filed 5–24–12; 8:45 am]
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
The meeting announced below
concerns Research to Enhance
Community-Based Fall Prevention
among Older Adults, SIP12–058, and
Developing a Compendium of Measures
and Questions to Assess Mobility: A
Focus on Older Adult Populations,
SIP12–059, Panel D, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–6:00 p.m., June
28, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Research to Enhance
Community-Based Fall Prevention among
Older Adults, SIP12–058, and Developing a
Compendium of Measures and Questions to
Assess Mobility: A Focus on Older Adult
Populations, SIP12–059, Panel D, initial
review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
VerDate Mar<15>2010
17:55 May 24, 2012
Jkt 226001
AL
Date closed
5/18/2012
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–12732 Filed 5–24–12; 8:45 am]
[FR Doc. 2012–12736 Filed 5–24–12; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Interest Projects (SIPs): Initial Review
State
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Interest Projects (SIPs): Initial Review
The meeting announced below
concerns Medical Resident Knowledge
and Practice in Physical Activity,
Nutrition, and Obesity Counseling for
Primary Prevention of Cancer, SIP12–
053, Panel C, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–6:00 p.m., June
26, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Medical Resident Knowledge
and Practice in Physical Activity, Nutrition,
and Obesity Counseling for Primary
Prevention of Cancer, SIP12–053, Panel C,
initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Interest Projects (SIPs): Initial Review
The meeting announced below
concerns Coordinating Center for the
Managing Epilepsy Well (MEW)
Prevention Research Centers Network,
SIP12–056, and Managing Epilepsy Well
(MEW) Collaborating Center for
Epilepsy Self-Management Intervention
Research, SIP12–057, Panel E, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11:00 a.m.–6:00 p.m., June
29, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Coordinating Center for the
Managing Epilepsy Well (MEW) Prevention
E:\FR\FM\25MYN1.SGM
25MYN1
Federal Register / Vol. 77, No. 102 / Friday, May 25, 2012 / Notices
Research Centers Network, SIP12–056, and
Managing Epilepsy Well (MEW)
Collaborating Center for Epilepsy SelfManagement Intervention Research, SIP12–
057, Panel E, initial review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: May 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–12730 Filed 5–24–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Board of Scientific Counselors,
National Center for Health Statistics
(BSC, NCHS)
Notice of Cancellation: This notice
was published in the Federal Register
on April 13, 2012, Volume 77, Number
72, page 22326. This meeting scheduled
to convene on May 17 and May 18,
2012, is cancelled due to lack of a
quorum. Notice will be provided when
the meeting is rescheduled in
accordance with section 10(a)(2) of the
Federal Advisory Committee Act (Pub.
L. 92–463).
Contact Person for More Information:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 7208, Hyattsville,
Maryland 20782, Telephone (301) 458–
4500, Fax (301) 458–4020, Email:
vcain@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: May 15, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–12295 Filed 5–24–12; 8:45 am]
BILLING CODE 4163–18–P
VerDate Mar<15>2010
17:55 May 24, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3257–N]
Medicare and Medicaid Programs;
Announcement of the Re-Approval of
the Joint Commission as an
Accreditation Organization Under the
Clinical Laboratory Improvement
Amendments of 1988
Centers for Medicare &
Medicaid Services (CMS), HHS.
AGENCY:
ACTION:
Notice.
This notice announces the
application of the Joint Commission for
re-approval as an accreditation
organization for clinical laboratories
under the Clinical Laboratory
Improvement Amendments of 1988
(CLIA) program for all specialty and
subspecialty areas under CLIA. We have
determined that the Joint Commission
meets or exceeds the applicable CLIA
requirements. We are announcing the
re-approval and granting the Joint
Commission deeming authority for a
period of 6 years.
SUMMARY:
This notice is effective from May
25, 2012 to May 25, 2018.
DATES:
FOR FURTHER INFORMATION CONTACT:
Kathleen Todd, (410) 786–3385.
SUPPLEMENTARY INFORMATION:
I. Background and Legislative
Authority
On October 31, 1988, the Congress
enacted the Clinical Laboratory
Improvement Amendments of 1988
(CLIA) (Pub. L. 100–578). CLIA
amended section 353 of the Public
Health Service Act. We issued a final
rule implementing the accreditation
provisions of CLIA on July 31, 1992 (57
FR 33992). Under those provisions, we
may grant deeming authority to an
accreditation organization if its
requirements for laboratories accredited
under its program are equal to or more
stringent than the applicable CLIA
program requirements in 42 CFR part
493 (Laboratory Requirements). Subpart
E of part 493 (Accreditation by a Private,
Nonprofit Accreditation Organization or
Exemption Under an Approved State
Laboratory Program) specifies the
requirements an accreditation
organization must meet to be approved
by CMS as an accreditation organization
under CLIA.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
31359
II. Notice of Approval of the Joint
Commission as an Accreditation
Organization
In this notice, we approve the Joint
Commission as an organization that may
accredit laboratories for purposes of
establishing its compliance with CLIA
requirements for all specialty and
subspecialty areas under CLIA. We have
examined the initial Joint Commission
application and all subsequent
submissions to determine its
accreditation program’s equivalency
with the requirements for approval of an
accreditation organization under
subpart E of part 493. We have
determined that the Joint Commission
meets or exceeds the applicable CLIA
requirements. We have also determined
that the Joint Commission will ensure
that its accredited laboratories will meet
or exceed the applicable requirements
in subparts H, I, J, K, M, Q, and the
applicable sections of R. Therefore, we
grant the Joint Commission approval as
an accreditation organization under
subpart E of part 493, for the period
stated in the DATES section of this notice
for all specialty and subspecialty areas
under CLIA. As a result of this
determination, any laboratory that is
accredited by the Joint Commission
during the time period stated in the
DATES section of this notice will be
deemed to meet the CLIA requirements
for the listed subspecialties and
specialties, and therefore, will generally
not be subject to routine inspections by
a State survey agency to determine its
compliance with CLIA requirements.
The accredited laboratory, however, is
subject to validation and complaint
investigation surveys performed by
CMS, or its agent(s).
III. Evaluation of the Joint Commission
Request for Approval as an
Accreditation Organization Under
CLIA
The following describes the process
used to determine that the Joint
Commission accreditation program
meets the necessary requirements to be
approved by CMS and that, as such,
CMS may approve the Joint Commission
as an accreditation program with
deeming authority under the CLIA
program. The Joint Commission
formally applied to CMS for approval as
an accreditation organization under
CLIA for all specialties and
subspecialties under CLIA. In reviewing
these materials, we reached the
following determinations for each
applicable part of the CLIA regulations:
E:\FR\FM\25MYN1.SGM
25MYN1
]]>Agencies
[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Pages 31358-31359]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12730]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Interest Projects (SIPs): Initial Review
The meeting announced below concerns Coordinating Center for the
Managing Epilepsy Well (MEW) Prevention Research Centers Network,
SIP12-056, and Managing Epilepsy Well (MEW) Collaborating Center for
Epilepsy Self-Management Intervention Research, SIP12-057, Panel E,
initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 11:00 a.m.-6:00 p.m., June 29, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of ``Coordinating Center for the
Managing Epilepsy Well (MEW) Prevention
[[Page 31359]]
Research Centers Network, SIP12-056, and Managing Epilepsy Well
(MEW) Collaborating Center for Epilepsy Self-Management Intervention
Research, SIP12-057, Panel E, initial review.''
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
46, Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: May 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-12730 Filed 5-24-12; 8:45 am]
BILLING CODE 4163-18-P
